Louise Frederika Kooij, Chief Accounting Officer at NewAmsterdam Pharma Co N.V. (NAMS), sold 300,000 shares at $26.11 ($7.7M) on 2025-09-09, disclosed to the SEC on 2025-09-10.
Open-market sale of $7.7M NAMS by Chief Accounting Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.31 | 53,104 | $1.3M | 17.3% |
| 2 | $25.31 | 53,104 | $1.3M | 17.3% |
| 3 | $26.11 | 96,896 | $2.5M | 32.7% |
| 4 | $26.11 | 96,896 | $2.5M | 32.7% |
| Total | $25.83 avg | 300,000 | $7.7M | 100% |
| Filing → |
| NAMS | SELL | 2026-05-27 | $2.3M | — | Filing → |
| NAMS | SELL | 2026-01-29 | $2.3M | — | Filing → |
| NAMS | SELL | 2026-01-27 | $2.4M | — | Filing → |